Epigenetic alterations and autoimmune disease.

Yves Renaudineau (1, 2) , D Beauvillard (2) , M Padelli (3, 2) , W H Brooks (4) , P Youinou (2)

1 Laboratoire d'Immunologie et Immunothérapie
2 EA2216 - Immunologie et Pathologie
3 LabEX IGO Immunothérapie Grand Ouest
4 Experimental HTS, Drug Discovery Department, Mofitt Cancer Center, Tampa, FL, USA.

Recent advances in epigenetics have enhanced our knowledge of how environmental factors (UV radiation, drugs, infections, etc.) contribute to the development of autoimmune diseases (AID) in genetically predisposed individuals. Studies conducted in monozygotic twins discordant for AID and spontaneous autoimmune animal models have highlighted the importance of DNA methylation changes and histone modifications. Alterations in the epigenetic pattern seem to be cell specific, as CD4+ T cells and B cells are dysregulated in systemic lupus erythematosus, synovial fibroblasts in rheumatoid arthritis and cerebral cells in multiple sclerosis. With regard to lymphocytes, the control of tolerance is affected, leading to the development of autoreactive cells. Other epigenetic processes, such as the newly described miRNAs, and post-translational protein modifications may also be suspected. Altogether, a conceptual revolution is in progress, in AID, with potential new therapeutic strategies targeting epigenetic patterns.

Domaines: Immunologie

Yves Renaudineau, D Beauvillard, M Padelli, W H Brooks, P Youinou. Epigenetic alterations and autoimmune disease.. Journal of Developmental Origins of Health and Disease, 2011, 2 (5), pp.258-64. ⟨hal-01163327⟩